Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+11.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$18.15M+40.5%
2024$12.92M-16.0%
2023$15.38M+16.3%
2022$13.23M+38.6%
2021$9.54M-
2020$0.00-